The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

AC1NSTAT     2-acetyloxyethyl-trimethyl- azanium hydroxide

Synonyms: 2-acetyloxyethyl(trimethyl)azanium hydroxide
This record was replaced with 187.
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Bromoacetylcholine


Psychiatry related information on Bromoacetylcholine


High impact information on Bromoacetylcholine


Chemical compound and disease context of Bromoacetylcholine


Biological context of Bromoacetylcholine

  • The integrity of these fibers was assessed objectively by measuring axon reflex vasodilation in response to stimulation with 10 percent acetylcholine introduced by electrophoresis [20].
  • The total number of alpha-bungarotoxin binding sites was reduced by 30% in the presence of carbachol, indicating that this agent affects the rate of synthesis of the acetylcholine receptor [21].
  • METHODS: We randomly assigned 19 patients with coronary endothelial dysfunction, indicated by abnormal acetylcholine-induced vasoconstriction, to an exercise-training group (10 patients) or a control group (9 patients) [22].
  • The kinetics of labeling of the "pool" and "surface" receptors with 2H, 13C, 15N-amino acids confirm the "precursor-product" type relationship of pool and surface acetylcholine receptors [23].
  • The responses of blood flow and vascular resistance to acetylcholine were significantly reduced in the hypertensive patients (P less than 0.0001); maximal forearm flow was 9.1 +/- 5 ml per minute per 100 ml in the patients and 20.0 +/- 8 ml per minute per 100 ml in the controls (P less than 0.0002) [24].

Anatomical context of Bromoacetylcholine


Associations of Bromoacetylcholine with other chemical compounds


Gene context of Bromoacetylcholine


Analytical, diagnostic and therapeutic context of Bromoacetylcholine


  1. Immunology of acetylcholine receptors in relation to myasthenia gravis. Vincent, A. Physiol. Rev. (1980) [Pubmed]
  2. 3,4-Diaminopyridine in the treatment of Lambert-Eaton myasthenic syndrome. McEvoy, K.M., Windebank, A.J., Daube, J.R., Low, P.A. N. Engl. J. Med. (1989) [Pubmed]
  3. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. Ludmer, P.L., Selwyn, A.P., Shook, T.L., Wayne, R.R., Mudge, G.H., Alexander, R.W., Ganz, P. N. Engl. J. Med. (1986) [Pubmed]
  4. First genetic evidence of GABA(A) receptor dysfunction in epilepsy: a mutation in the gamma2-subunit gene. Baulac, S., Huberfeld, G., Gourfinkel-An, I., Mitropoulou, G., Beranger, A., Prud'homme, J.F., Baulac, M., Brice, A., Bruzzone, R., LeGuern, E. Nat. Genet. (2001) [Pubmed]
  5. Neurochemical studies of early-onset Alzheimer's disease. Possible influence on treatment. Francis, P.T., Palmer, A.M., Sims, N.R., Bowen, D.M., Davison, A.N., Esiri, M.M., Neary, D., Snowden, J.S., Wilcock, G.K. N. Engl. J. Med. (1985) [Pubmed]
  6. Age-impaired impulse flow from nucleus basalis to cortex. Aston-Jones, G., Rogers, J., Shaver, R.D., Dinan, T.G., Moss, D.E. Nature (1985) [Pubmed]
  7. Identification of sleep-promoting neurons in vitro. Gallopin, T., Fort, P., Eggermann, E., Cauli, B., Luppi, P.H., Rossier, J., Audinat, E., Mühlethaler, M., Serafin, M. Nature (2000) [Pubmed]
  8. Acute stress facilitates long-lasting changes in cholinergic gene expression. Kaufer, D., Friedman, A., Seidman, S., Soreq, H. Nature (1998) [Pubmed]
  9. Human serial learning: enhancement with arecholine and choline impairment with scopolamine. Sitaram, N., Weingartner, H., Gillin, J.C. Science (1978) [Pubmed]
  10. Conus peptides targeted to specific nicotinic acetylcholine receptor subtypes. McIntosh, J.M., Santos, A.D., Olivera, B.M. Annu. Rev. Biochem. (1999) [Pubmed]
  11. Calcium signaling and exocytosis in adrenal chromaffin cells. Garc??a, A.G., Garc??a-De-Diego, A.M., Gand??a, L., Borges, R., Garc??a-Sancho, J. Physiol. Rev. (2006) [Pubmed]
  12. Physiological regulation of G protein-linked signaling. Morris, A.J., Malbon, C.C. Physiol. Rev. (1999) [Pubmed]
  13. Acetylcholine receptor gene expression at the developing neuromuscular junction. Duclert, A., Changeux, J.P. Physiol. Rev. (1995) [Pubmed]
  14. Control of acetylcholine receptors in skeletal muscle. Fambrough, D.M. Physiol. Rev. (1979) [Pubmed]
  15. Biochemical evidence of dysfunction of brain neurotransmitters in the Lesch-Nyhan syndrome. Lloyd, K.G., Hornykiewicz, O., Davidson, L., Shannak, K., Farley, I., Goldstein, M., Shibuya, M., Kelley, W.N., Fox, I.H. N. Engl. J. Med. (1981) [Pubmed]
  16. Impairment of endothelium-dependent pulmonary-artery relaxation in chronic obstructive lung disease. Dinh-Xuan, A.T., Higenbottam, T.W., Clelland, C.A., Pepke-Zaba, J., Cremona, G., Butt, A.Y., Large, S.R., Wells, F.C., Wallwork, J. N. Engl. J. Med. (1991) [Pubmed]
  17. Amino acid sequence similarity between rabies virus glycoprotein and snake venom curaremimetic neurotoxins. Lentz, T.L., Wilson, P.T., Hawrot, E., Speicher, D.W. Science (1984) [Pubmed]
  18. Muscarinic acetylcholine receptors in Alzheimer's disease. In vivo imaging with iodine 123-labeled 3-quinuclidinyl-4-iodobenzilate and emission tomography. Holman, B.L., Gibson, R.E., Hill, T.C., Eckelman, W.C., Albert, M., Reba, R.C. JAMA (1985) [Pubmed]
  19. Preeclampsia selectively impairs endothelium-dependent relaxation and leads to oscillatory activity in small omental arteries. Pascoal, I.F., Lindheimer, M.D., Nalbantian-Brandt, C., Umans, J.G. J. Clin. Invest. (1998) [Pubmed]
  20. Impaired neurogenic vascular response in patients with diabetes and neuropathic foot lesions. Parkhouse, N., Le Quesne, P.M. N. Engl. J. Med. (1988) [Pubmed]
  21. Acetylcholine receptor degradation measured by density labeling: effects of cholinergic ligands and evidence against recycling. Gardner, J.M., Fambrough, D.M. Cell (1979) [Pubmed]
  22. Effect of exercise on coronary endothelial function in patients with coronary artery disease. Hambrecht, R., Wolf, A., Gielen, S., Linke, A., Hofer, J., Erbs, S., Schoene, N., Schuler, G. N. Engl. J. Med. (2000) [Pubmed]
  23. Kinetics of biosynthesis of acetylcholine receptor and subsequent incorporation into plasma membrane of cultured chick skeletal muscle. Devreotes, P.N., Gardner, J.M., Fambrough, D.M. Cell (1977) [Pubmed]
  24. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. Panza, J.A., Quyyumi, A.A., Brush, J.E., Epstein, S.E. N. Engl. J. Med. (1990) [Pubmed]
  25. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. Anderson, T.J., Meredith, I.T., Yeung, A.C., Frei, B., Selwyn, A.P., Ganz, P. N. Engl. J. Med. (1995) [Pubmed]
  26. Degradation of the acetylcholine receptor in cultured muscle cells: selective inhibitors and the fate of undegraded receptors. Libby, P., Bursztajn, S., Goldberg, A.L. Cell (1980) [Pubmed]
  27. Direct observation of the rapid aggregation of acetylcholine receptors on identified cultured myotubes after exposure to embryonic brain extract. Olek, A.J., Pudimat, P.A., Daniels, M.P. Cell (1983) [Pubmed]
  28. Alpha 9: an acetylcholine receptor with novel pharmacological properties expressed in rat cochlear hair cells. Elgoyhen, A.B., Johnson, D.S., Boulter, J., Vetter, D.E., Heinemann, S. Cell (1994) [Pubmed]
  29. Difference between endothelium-dependent relaxation in arterial and in venous coronary bypass grafts. Lüscher, T.F., Diederich, D., Siebenmann, R., Lehmann, K., Stulz, P., von Segesser, L., Yang, Z.H., Turina, M., Grädel, E., Weber, E. N. Engl. J. Med. (1988) [Pubmed]
  30. Oral choline administration to patients with tardive dyskinesia. Growdon, J.H., Hirsch, M.J., Wurtman, R.J., Wiener, W. N. Engl. J. Med. (1977) [Pubmed]
  31. Huntington's chorea. Changes in neurotransmitter receptors in the brain. Enna, S.J., Bird, E.D., Bennett, J.P., Bylund, D.B., Yamamura, H.I., Iversen, L.L., Snyder, S.H. N. Engl. J. Med. (1976) [Pubmed]
  32. The small GTP-binding protein RhoA regulates a delayed rectifier potassium channel. Cachero, T.G., Morielli, A.D., Peralta, E.G. Cell (1998) [Pubmed]
  33. Manipulation of myogenesis in vitro: reversible inhibition by DMSO. Blau, H.M., Epstein, C.J. Cell (1979) [Pubmed]
  34. A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy. Steinlein, O.K., Mulley, J.C., Propping, P., Wallace, R.H., Phillips, H.A., Sutherland, G.R., Scheffer, I.E., Berkovic, S.F. Nat. Genet. (1995) [Pubmed]
  35. Mice lacking the M3 muscarinic acetylcholine receptor are hypophagic and lean. Yamada, M., Miyakawa, T., Duttaroy, A., Yamanaka, A., Moriguchi, T., Makita, R., Ogawa, M., Chou, C.J., Xia, B., Crawley, J.N., Felder, C.C., Deng, C.X., Wess, J. Nature (2001) [Pubmed]
  36. The Caenorhabditis elegans unc-17 gene: a putative vesicular acetylcholine transporter. Alfonso, A., Grundahl, K., Duerr, J.S., Han, H.P., Rand, J.B. Science (1993) [Pubmed]
  37. Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway. de Jonge, W.J., van der Zanden, E.P., The, F.O., Bijlsma, M.F., van Westerloo, D.J., Bennink, R.J., Berthoud, H.R., Uematsu, S., Akira, S., van den Wijngaard, R.M., Boeckxstaens, G.E. Nat. Immunol. (2005) [Pubmed]
  38. Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity. Corry, D.B., Folkesson, H.G., Warnock, M.L., Erle, D.J., Matthay, M.A., Wiener-Kronish, J.P., Locksley, R.M. J. Exp. Med. (1996) [Pubmed]
  39. Abnormal myocardial phosphorus-31 nuclear magnetic resonance spectroscopy in women with chest pain but normal coronary angiograms. Buchthal, S.D., den Hollander, J.A., Merz, C.N., Rogers, W.J., Pepine, C.J., Reichek, N., Sharaf, B.L., Reis, S., Kelsey, S.F., Pohost, G.M. N. Engl. J. Med. (2000) [Pubmed]
  40. The effect of atherosclerosis on the vasomotor response of coronary arteries to mental stress. Yeung, A.C., Vekshtein, V.I., Krantz, D.S., Vita, J.A., Ryan, T.J., Ganz, P., Selwyn, A.P. N. Engl. J. Med. (1991) [Pubmed]
  41. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. Treasure, C.B., Klein, J.L., Weintraub, W.S., Talley, J.D., Stillabower, M.E., Kosinski, A.S., Zhang, J., Boccuzzi, S.J., Cedarholm, J.C., Alexander, R.W. N. Engl. J. Med. (1995) [Pubmed]
  42. Assembly in vivo of mouse muscle acetylcholine receptor: identification of an alpha subunit species that may be an assembly intermediate. Merlie, J.P., Lindstrom, J. Cell (1983) [Pubmed]
WikiGenes - Universities